A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelants Union of Health Insurance Companies, Zentiva, k.s., Xantis Pharma Limited, Adamed Pharma S.A., against the decision of the State Institute for Drug Control from 28. 2. 2020 under the no: SUKLS27614/2017:
the decision under
appeal is reversed and the issue is referred back to the State Institute for
Drug Control for reappraisal.
A decision of the Ministry of Health regarding the appeal of the appelants Union of Health Insurance Companies, Zentiva, k.s., Xantis Pharma Limited, Adamed Pharma S.A. - the decision is reversed...
A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelants Union of Health Insurance Companies, against the decision of the State Institute for Drug Control from 31. 3. 2020, under the no.: SUKLS220471/2019:
the operative part 2 of the decision under
appeal is reversed and the issue is referred back to the State Institute for
Drug Control for reappraisal.
A decision of the Ministry of Health regarding the appeal of the appelants Union of Health Insurance Companies - part of the decision is reversed and the rest is upheld.
A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant Union of Health Insurance Companies, against the decision of the State Institute for Drug Control from 15. 4. 2020, under the no: SUKLS27746/2020:
the remainder of the appeal is dismissed and the decision under appeal is upheld.
A decision of the Ministry of Health regarding the appeal of the appelant Union of Health Insurance Companies - the appeal is dismissed and the decision under appeal is upheld.
A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant Bristol-Myers Squibb Pharma EEIG, against the decision of the State Institute for Drug Control from e 3. 3. 2020, under the no. SUKLS298091/2019:
the remainder of the appeal is dismissed and the decision under appeal is upheld.
A decision of the Ministry of Health regarding the appeal of the appelant Bristol-Myers Squibb Pharma EEIG - the appeal is dismissed and the decision under appeal is upheld.
A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant Alexion Europe SAS, against the decision of the State Institute for Drug Control from 30. 6. 2021, under the no.: SUKLS329859/2019:
the decision is reversed and the proceedings are terminated.
A decision of the Ministry of Health regarding the appeal of the appelant Alexion Europe SAS - the decision is reversed and the proceedings are terminated.
A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant SANOFI-AVENTIS DEUTSCHLAND GMBH, against the decision of the State Institute for Drug Control from e 3. 3. 2020, under the no. SUKLS298091/2019:
the remainder of the appeal is dismissed and the decision under appeal is upheld.
A decision of the Ministry of Health regarding the appeal of the appelant SANOFI-AVENTIS DEUTSCHLAND GMBH - the appeal is dismissed and the decision under appeal is upheld.
A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant B. Braun Melsungen AG, against the decision of the State Institute for Drug Control from 07.02.2020, under the no.: SUKLS293518/2019:
the remainder of the appeal is dismissed and the decision under appeal is upheld.
A decision of the Ministry of Health regarding the appeal of the appelant B. Braun Melsungen AG - the appeal is dismissed and the decision under appeal is upheld.
A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant AstraZeneca AB, against the decision of the State Institute for Drug Control from 5.2.2020, under the no.: SUKLS314006/2018:
the remainder of the appeal is dismissed and the decision under appeal is upheld.
A decision of the Ministry of Health regarding the appeal of the appelant AstraZeneca AB - the appeal is dismissed and the decision under appeal is upheld.
